GASTROINTESTINAL STROMAL TUMORS
Clinical trials for GASTROINTESTINAL STROMAL TUMORS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL STROMAL TUMORS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Chemotherapy drug paclitaxel tested for Hard-to-Treat GIST
Disease control CompletedThis phase II trial tested the chemotherapy drug paclitaxel in 40 patients with advanced or metastatic gastrointestinal stromal tumor (GIST) whose cancer had stopped responding to three standard treatments: imatinib, sunitinib, and regorafenib. The study focused on patients with …
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug shows promise for rare stomach cancer in chinese patients
Disease control CompletedThis study looked at how safe and effective the drug avapritinib is for Chinese patients with a rare type of stomach cancer called gastrointestinal stromal tumor (GIST). Researchers observed 61 patients in real-world clinics, not in a controlled lab setting. The goal was to track…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug shows promise in controlling advanced GIST tumors
Disease control CompletedThis phase 4 trial tested the drug nilotinib in 34 adults with advanced GIST that could not be removed by surgery. The goal was to see how many patients had their tumors shrink or stay stable after 6 months. Researchers measured response using standard tumor scans. The study prov…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New combo therapy shows promise for Hard-to-Treat gut cancer
Disease control CompletedThis study tested a combination of two drugs—avelumab (an immunotherapy) and axitinib (a targeted therapy)—in 58 adults with advanced gastrointestinal stromal tumor (GIST) that had worsened after standard treatments. The main goal was to see how many patients were still cancer-fr…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Phase: PHASE2 • Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology • Aim: Disease control
Last updated Jun 26, 2026 16:23 UTC
-
AI reads scans and slides to outsmart stomach cancer
Diagnosis CompletedThis study tested an artificial intelligence model that combines CT scans, digital pathology images, and patient history to improve diagnosis and risk prediction for gastrointestinal stromal tumors (GISTs). Researchers enrolled 300 patients with suspected stomach tumors. The AI a…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Sponsor: Qun Zhao • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
Study aims to pinpoint ideal imatinib dose for GIST patients
Knowledge-focused CompletedThis completed study looked at 328 patients with intermediate or high-risk gastrointestinal stromal tumors (GISTs) who took imatinib after surgery. The goal was to find the best dose that balances effectiveness in preventing tumor return with the risk of side effects. Researchers…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC